 Daniel Olson
Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Guatemala | 20 | 2025 | 343 | 1.450 |
Why?
| | Dengue | 4 | 2024 | 91 | 1.420 |
Why?
| | Zika Virus Infection | 6 | 2024 | 172 | 1.340 |
Why?
| | Arbovirus Infections | 2 | 2019 | 20 | 1.120 |
Why?
| | Microcephaly | 4 | 2024 | 104 | 1.070 |
Why?
| | Caliciviridae Infections | 2 | 2018 | 18 | 1.060 |
Why?
| | Zika Virus | 5 | 2024 | 136 | 1.050 |
Why?
| | Norovirus | 2 | 2018 | 22 | 1.050 |
Why?
| | Dengue Virus | 4 | 2024 | 60 | 1.030 |
Why?
| | Viral Vaccines | 2 | 2018 | 107 | 1.010 |
Why?
| | Gastroenteritis | 2 | 2017 | 63 | 0.990 |
Why?
| | Disease Outbreaks | 4 | 2024 | 419 | 0.820 |
Why?
| | Child Development | 6 | 2025 | 483 | 0.780 |
Why?
| | Vital Signs | 2 | 2013 | 46 | 0.760 |
Why?
| | Rural Population | 10 | 2025 | 660 | 0.690 |
Why?
| | Hospitals | 4 | 2016 | 733 | 0.640 |
Why?
| | Triage | 2 | 2013 | 250 | 0.640 |
Why?
| | Stevens-Johnson Syndrome | 2 | 2017 | 37 | 0.640 |
Why?
| | Sentinel Surveillance | 2 | 2017 | 46 | 0.630 |
Why?
| | Global Health | 2 | 2022 | 403 | 0.590 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2018 | 1419 | 0.590 |
Why?
| | Fever | 2 | 2017 | 319 | 0.570 |
Why?
| | Infant | 21 | 2025 | 10089 | 0.500 |
Why?
| | Public Health | 2 | 2019 | 574 | 0.490 |
Why?
| | Cell Phone | 1 | 2017 | 82 | 0.490 |
Why?
| | Health Policy | 1 | 2019 | 400 | 0.450 |
Why?
| | Encephalomyelitis, Acute Disseminated | 1 | 2015 | 11 | 0.450 |
Why?
| | Typhoid Fever | 1 | 2015 | 12 | 0.440 |
Why?
| | Health Information Systems | 1 | 2015 | 16 | 0.440 |
Why?
| | Severity of Illness Index | 2 | 2013 | 2933 | 0.440 |
Why?
| | Meningitis, Bacterial | 1 | 2015 | 46 | 0.430 |
Why?
| | Mobile Applications | 1 | 2017 | 199 | 0.430 |
Why?
| | Paralysis | 1 | 2015 | 69 | 0.430 |
Why?
| | Malaria | 1 | 2015 | 72 | 0.410 |
Why?
| | Child, Preschool | 18 | 2025 | 11866 | 0.400 |
Why?
| | Population Surveillance | 1 | 2017 | 484 | 0.400 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 140 | 0.390 |
Why?
| | Allied Health Personnel | 1 | 2013 | 53 | 0.380 |
Why?
| | Communicable Diseases | 1 | 2015 | 166 | 0.370 |
Why?
| | Growth Disorders | 2 | 2023 | 89 | 0.360 |
Why?
| | Developing Countries | 2 | 2019 | 317 | 0.360 |
Why?
| | Health Resources | 1 | 2013 | 130 | 0.360 |
Why?
| | Patient Acceptance of Health Care | 1 | 2018 | 883 | 0.350 |
Why?
| | Hospital Mortality | 2 | 2013 | 1038 | 0.340 |
Why?
| | Hospitalization | 4 | 2015 | 2460 | 0.330 |
Why?
| | Serogroup | 3 | 2025 | 45 | 0.310 |
Why?
| | Child | 13 | 2022 | 22738 | 0.300 |
Why?
| | Streptococcus pneumoniae | 2 | 2025 | 186 | 0.300 |
Why?
| | Databases, Factual | 1 | 2015 | 1491 | 0.290 |
Why?
| | Infant, Newborn | 12 | 2025 | 6464 | 0.280 |
Why?
| | Humans | 38 | 2025 | 145750 | 0.270 |
Why?
| | Cross-Sectional Studies | 6 | 2025 | 5921 | 0.260 |
Why?
| | Mycoplasma pneumoniae | 2 | 2017 | 53 | 0.250 |
Why?
| | HIV Infections | 4 | 2015 | 3195 | 0.250 |
Why?
| | Family Characteristics | 2 | 2018 | 197 | 0.250 |
Why?
| | Seroepidemiologic Studies | 2 | 2024 | 171 | 0.230 |
Why?
| | Community-Acquired Infections | 2 | 2025 | 177 | 0.220 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2025 | 47 | 0.220 |
Why?
| | Ectoparasitic Infestations | 1 | 2024 | 5 | 0.220 |
Why?
| | Animals, Domestic | 1 | 2024 | 17 | 0.220 |
Why?
| | Antigens, Bacterial | 1 | 2025 | 126 | 0.210 |
Why?
| | Acute Disease | 2 | 2017 | 1036 | 0.210 |
Why?
| | Male | 22 | 2025 | 72992 | 0.210 |
Why?
| | Head | 1 | 2025 | 123 | 0.200 |
Why?
| | Culex | 1 | 2023 | 14 | 0.200 |
Why?
| | Malawi | 5 | 2014 | 57 | 0.200 |
Why?
| | Prospective Studies | 9 | 2025 | 8075 | 0.190 |
Why?
| | Aedes | 1 | 2023 | 66 | 0.190 |
Why?
| | Cross Reactions | 1 | 2022 | 130 | 0.180 |
Why?
| | Vomiting | 1 | 2023 | 131 | 0.180 |
Why?
| | Cough | 1 | 2023 | 124 | 0.180 |
Why?
| | Diarrhea | 1 | 2023 | 193 | 0.180 |
Why?
| | Masks | 1 | 2022 | 70 | 0.180 |
Why?
| | Adolescent | 7 | 2018 | 22569 | 0.170 |
Why?
| | Viruses | 1 | 2023 | 166 | 0.170 |
Why?
| | Neurodevelopmental Disorders | 1 | 2024 | 229 | 0.170 |
Why?
| | Female | 21 | 2025 | 79025 | 0.170 |
Why?
| | Yellow fever virus | 1 | 2020 | 4 | 0.160 |
Why?
| | Health Services Research | 2 | 2013 | 391 | 0.160 |
Why?
| | Yellow Fever | 1 | 2020 | 9 | 0.160 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 849 | 0.160 |
Why?
| | Neuropsychological Tests | 3 | 2020 | 1137 | 0.150 |
Why?
| | Language Tests | 1 | 2019 | 23 | 0.150 |
Why?
| | Cohort Studies | 5 | 2025 | 6032 | 0.150 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2020 | 337 | 0.150 |
Why?
| | Language Development Disorders | 1 | 2019 | 41 | 0.150 |
Why?
| | Americas | 1 | 2019 | 27 | 0.150 |
Why?
| | Motor Skills | 1 | 2020 | 104 | 0.140 |
Why?
| | Dengue Vaccines | 1 | 2018 | 11 | 0.140 |
Why?
| | Arboviruses | 1 | 2018 | 14 | 0.140 |
Why?
| | Sensitivity and Specificity | 4 | 2020 | 2000 | 0.140 |
Why?
| | Antibodies, Viral | 1 | 2022 | 674 | 0.140 |
Why?
| | Cities | 2 | 2016 | 139 | 0.140 |
Why?
| | Chlamydophila pneumoniae | 1 | 2017 | 12 | 0.130 |
Why?
| | Surveys and Questionnaires | 3 | 2021 | 6084 | 0.130 |
Why?
| | Mycoplasma Infections | 1 | 2017 | 17 | 0.130 |
Why?
| | Chikungunya Fever | 1 | 2018 | 82 | 0.130 |
Why?
| | Mouth Mucosa | 1 | 2017 | 85 | 0.130 |
Why?
| | Pneumonia, Mycoplasma | 1 | 2017 | 55 | 0.120 |
Why?
| | Antigens, Viral | 1 | 2017 | 182 | 0.120 |
Why?
| | Referral and Consultation | 2 | 2013 | 868 | 0.120 |
Why?
| | RNA, Viral | 1 | 2020 | 692 | 0.120 |
Why?
| | Analgesia, Obstetrical | 1 | 2016 | 33 | 0.120 |
Why?
| | Neonatal Screening | 1 | 2017 | 179 | 0.120 |
Why?
| | Analgesia, Epidural | 1 | 2016 | 39 | 0.120 |
Why?
| | Learning | 1 | 2020 | 444 | 0.110 |
Why?
| | ROC Curve | 2 | 2017 | 618 | 0.110 |
Why?
| | Data Collection | 1 | 2018 | 643 | 0.110 |
Why?
| | Point-of-Care Systems | 2 | 2014 | 189 | 0.110 |
Why?
| | Pneumococcal Infections | 1 | 2016 | 104 | 0.110 |
Why?
| | Reference Values | 2 | 2014 | 798 | 0.110 |
Why?
| | Risk Factors | 3 | 2025 | 10916 | 0.110 |
Why?
| | Hospitals, Pediatric | 2 | 2017 | 558 | 0.110 |
Why?
| | Clinical Medicine | 1 | 2014 | 26 | 0.100 |
Why?
| | Biomarkers | 1 | 2025 | 4302 | 0.100 |
Why?
| | Travel | 1 | 2015 | 136 | 0.100 |
Why?
| | Chickens | 2 | 2024 | 179 | 0.100 |
Why?
| | CD4 Lymphocyte Count | 1 | 2014 | 280 | 0.100 |
Why?
| | Clinical Laboratory Techniques | 1 | 2014 | 96 | 0.100 |
Why?
| | Molecular Diagnostic Techniques | 1 | 2014 | 104 | 0.100 |
Why?
| | Child, Hospitalized | 1 | 2013 | 54 | 0.090 |
Why?
| | Confidence Intervals | 1 | 2013 | 330 | 0.090 |
Why?
| | Respiration | 1 | 2013 | 207 | 0.090 |
Why?
| | Area Under Curve | 1 | 2013 | 332 | 0.090 |
Why?
| | Caregivers | 1 | 2021 | 1073 | 0.090 |
Why?
| | Infectious Disease Transmission, Vertical | 1 | 2014 | 194 | 0.090 |
Why?
| | Psychometrics | 3 | 2021 | 731 | 0.090 |
Why?
| | Survival Analysis | 1 | 2015 | 1378 | 0.090 |
Why?
| | Anti-Retroviral Agents | 1 | 2014 | 251 | 0.090 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2016 | 440 | 0.090 |
Why?
| | Reproducibility of Results | 4 | 2021 | 3416 | 0.090 |
Why?
| | Workload | 1 | 2013 | 169 | 0.080 |
Why?
| | Aged, 80 and over | 1 | 2023 | 8346 | 0.080 |
Why?
| | Odds Ratio | 1 | 2013 | 1083 | 0.080 |
Why?
| | Temperature | 1 | 2013 | 633 | 0.080 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2013 | 303 | 0.080 |
Why?
| | Ambulatory Care Facilities | 1 | 2012 | 269 | 0.080 |
Why?
| | Health Personnel | 2 | 2014 | 755 | 0.080 |
Why?
| | Sepsis | 1 | 2016 | 664 | 0.080 |
Why?
| | Heart Rate | 1 | 2013 | 856 | 0.070 |
Why?
| | Anti-Bacterial Agents | 2 | 2017 | 1925 | 0.070 |
Why?
| | Oxygen | 1 | 2013 | 981 | 0.070 |
Why?
| | Logistic Models | 1 | 2013 | 2139 | 0.070 |
Why?
| | Pneumonia | 1 | 2013 | 636 | 0.070 |
Why?
| | Adult | 6 | 2025 | 40867 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1146 | 0.060 |
Why?
| | Communication | 1 | 2013 | 976 | 0.060 |
Why?
| | Animals | 4 | 2024 | 38100 | 0.060 |
Why?
| | Algorithms | 1 | 2014 | 1850 | 0.060 |
Why?
| | Glucagon-Like Peptide 2 | 1 | 2025 | 7 | 0.060 |
Why?
| | Inflammation | 1 | 2017 | 2883 | 0.060 |
Why?
| | Case-Control Studies | 1 | 2013 | 3634 | 0.060 |
Why?
| | Delivery of Health Care | 1 | 2012 | 947 | 0.060 |
Why?
| | Anaplasma | 1 | 2024 | 3 | 0.060 |
Why?
| | Ehrlichia | 1 | 2024 | 4 | 0.060 |
Why?
| | Bartonella | 1 | 2024 | 8 | 0.050 |
Why?
| | Rickettsia | 1 | 2024 | 11 | 0.050 |
Why?
| | Siphonaptera | 1 | 2024 | 14 | 0.050 |
Why?
| | Ticks | 1 | 2024 | 30 | 0.050 |
Why?
| | Cats | 1 | 2024 | 234 | 0.050 |
Why?
| | South America | 1 | 2024 | 56 | 0.050 |
Why?
| | Quality Improvement | 1 | 2013 | 1296 | 0.050 |
Why?
| | Dog Diseases | 1 | 2024 | 106 | 0.050 |
Why?
| | Mosquito Vectors | 1 | 2023 | 31 | 0.050 |
Why?
| | Dogs | 1 | 2024 | 478 | 0.050 |
Why?
| | Pregnancy | 3 | 2024 | 7215 | 0.050 |
Why?
| | Brain | 1 | 2015 | 2969 | 0.050 |
Why?
| | Personal Protective Equipment | 1 | 2022 | 58 | 0.050 |
Why?
| | Observational Studies as Topic | 1 | 2022 | 134 | 0.040 |
Why?
| | Swine | 1 | 2024 | 826 | 0.040 |
Why?
| | Mammals | 1 | 2023 | 286 | 0.040 |
Why?
| | Anthropometry | 1 | 2022 | 206 | 0.040 |
Why?
| | International Cooperation | 1 | 2022 | 197 | 0.040 |
Why?
| | Respiratory Tract Infections | 1 | 2025 | 396 | 0.040 |
Why?
| | Socioeconomic Factors | 1 | 2025 | 1327 | 0.040 |
Why?
| | Paraguay | 1 | 2020 | 3 | 0.040 |
Why?
| | Sri Lanka | 1 | 2020 | 7 | 0.040 |
Why?
| | Endemic Diseases | 1 | 2020 | 33 | 0.040 |
Why?
| | Reagent Kits, Diagnostic | 1 | 2020 | 33 | 0.040 |
Why?
| | Translations | 1 | 2020 | 18 | 0.040 |
Why?
| | Regression Analysis | 1 | 2022 | 1001 | 0.040 |
Why?
| | Child Language | 1 | 2019 | 21 | 0.040 |
Why?
| | Translating | 1 | 2019 | 50 | 0.040 |
Why?
| | Rural Health | 1 | 2019 | 87 | 0.040 |
Why?
| | Culturally Competent Care | 1 | 2019 | 72 | 0.030 |
Why?
| | Viral Load | 1 | 2020 | 526 | 0.030 |
Why?
| | Chromatography, Affinity | 1 | 2017 | 80 | 0.030 |
Why?
| | Epitope Mapping | 1 | 2017 | 61 | 0.030 |
Why?
| | Contact Tracing | 1 | 2017 | 26 | 0.030 |
Why?
| | Molecular Epidemiology | 1 | 2017 | 74 | 0.030 |
Why?
| | United States | 1 | 2015 | 16122 | 0.030 |
Why?
| | Macrolides | 1 | 2017 | 67 | 0.030 |
Why?
| | Sequence Alignment | 1 | 2017 | 362 | 0.030 |
Why?
| | Colorado | 2 | 2017 | 4556 | 0.030 |
Why?
| | Microbial Sensitivity Tests | 1 | 2017 | 365 | 0.030 |
Why?
| | Pneumococcal Vaccines | 1 | 2016 | 129 | 0.030 |
Why?
| | Young Adult | 2 | 2024 | 14250 | 0.030 |
Why?
| | World Health Organization | 1 | 2014 | 104 | 0.030 |
Why?
| | Amino Acid Sequence | 1 | 2017 | 2131 | 0.020 |
Why?
| | Pandemics | 1 | 2022 | 1711 | 0.020 |
Why?
| | Random Allocation | 1 | 2014 | 365 | 0.020 |
Why?
| | Urban Population | 1 | 2016 | 494 | 0.020 |
Why?
| | HIV | 1 | 2012 | 251 | 0.020 |
Why?
| | DNA, Viral | 1 | 2012 | 356 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 2017 | 1505 | 0.020 |
Why?
| | Inpatients | 1 | 2014 | 553 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1043 | 0.020 |
Why?
| | Middle Aged | 2 | 2017 | 36297 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2016 | 17322 | 0.010 |
Why?
|
|
Olson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|